@y-lyratzopoulos.bsky.social
Reposted
Prostate cancer testing when men have no symptoms varies widely between GP practices, according to a new study involving Nadine Zakkak and Prof Yoryos Lyratzopoulos @y-lyratzopoulos.bsky.social @uclpophealthsci.bsky.social which "highlights the need for evidence from high-quality clinical trials"
Prostate cancer testing varies widely between GP practices
A large-scale study involving UCL researchers has found huge variation between GP practices on whether they are likely to pick up prostate cancer using a blood test.
www.ucl.ac.uk
February 27, 2025 at 3:24 PM
Prostate cancer testing when men have no symptoms varies widely between GP practices, according to a new study involving Nadine Zakkak and Prof Yoryos Lyratzopoulos @y-lyratzopoulos.bsky.social @uclpophealthsci.bsky.social which "highlights the need for evidence from high-quality clinical trials"
Reposted
Prostate cancer testing when men have no symptoms varies widely between GP practices, according to a new study involving Nadine Zakkak and Prof Yoryos Lyratzopoulos
@y-lyratzopoulos.bsky.social which "highlights the need for evidence from high-quality clinical trials"
@y-lyratzopoulos.bsky.social which "highlights the need for evidence from high-quality clinical trials"
Prostate cancer testing varies widely between GP practices
A large-scale study involving UCL researchers has found huge variation between GP practices on whether they are likely to pick up prostate cancer using a blood test.
buff.ly
March 5, 2025 at 8:57 AM
Prostate cancer testing when men have no symptoms varies widely between GP practices, according to a new study involving Nadine Zakkak and Prof Yoryos Lyratzopoulos
@y-lyratzopoulos.bsky.social which "highlights the need for evidence from high-quality clinical trials"
@y-lyratzopoulos.bsky.social which "highlights the need for evidence from high-quality clinical trials"
Reposted
A huge thank you to our funders for making this possible! It’s been truly inspiring to work alongside an extraordinary community of co-investigators & patient and public partners, in developing the proposals. Deeply grateful for the constant support from the central CRUK team throughout the process.
Together with the NIHR (National Institute for Health and Care Research), the EPSRC, Health Data Research UK (HDR UK) and ADR UK (Administrative Data Research UK), we’re announcing a £10m programme which will help identify individual cancer risk 🙌
Read more 👉 cruk.ink/42q0aaY
Read more 👉 cruk.ink/42q0aaY
£10m funding for new programme to help identify individual cancer risk - Cancer Research UK - Cancer News
Today, Cancer Research UK, the NIHR and the EPSRC are announcing £10 million to create the Cancer Data-Driven Detection programme
cruk.ink
January 22, 2025 at 5:38 PM
A huge thank you to our funders for making this possible! It’s been truly inspiring to work alongside an extraordinary community of co-investigators & patient and public partners, in developing the proposals. Deeply grateful for the constant support from the central CRUK team throughout the process.
Reposted
Together with the NIHR (National Institute for Health and Care Research), the EPSRC, Health Data Research UK (HDR UK) and ADR UK (Administrative Data Research UK), we’re announcing a £10m programme which will help identify individual cancer risk 🙌
Read more 👉 cruk.ink/42q0aaY
Read more 👉 cruk.ink/42q0aaY
£10m funding for new programme to help identify individual cancer risk - Cancer Research UK - Cancer News
Today, Cancer Research UK, the NIHR and the EPSRC are announcing £10 million to create the Cancer Data-Driven Detection programme
cruk.ink
January 22, 2025 at 10:02 AM
Together with the NIHR (National Institute for Health and Care Research), the EPSRC, Health Data Research UK (HDR UK) and ADR UK (Administrative Data Research UK), we’re announcing a £10m programme which will help identify individual cancer risk 🙌
Read more 👉 cruk.ink/42q0aaY
Read more 👉 cruk.ink/42q0aaY